MedTrace Logo

A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients

NCT07101874 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 729

Last updated 2026-04-17

No results posted yet for this study

Summary

This is a multi-center, retrospective, observational study of patients receiving first-line systemic therapy as routine clinical care for unresectable BTC in Japan. This study attempts to test the hypothesis that the occurrence of biliary complications requiring hospitalization during first-line systemic therapy for unresectable BTC, which is as a time-dependent covariate, affects time to treatment failure (TTF) .

Conditions

  • Biliary Tract Cancer

Sponsors & Collaborators

  • Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)

    collaborator UNKNOWN

  • AstraZeneca

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-22
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07101874 on ClinicalTrials.gov